The University of Kansas Cancer Center - Investigational Drug Services — Westwood, Kansas

The University of Kansas Cancer Center - Investigational Drug Services is a clinical research site located in Westwood, Kansas, United States 66205.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

The University of Kansas Cancer Center - Investigational Drug Services has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Breast Neoplasms, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Kansas Cancer Center - Investigational Drug Services?

The University of Kansas Cancer Center - Investigational Drug Services has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Kansas Cancer Center - Investigational Drug Services conducted?

The University of Kansas Cancer Center - Investigational Drug Services has 2 clinical trials on record, with 1 currently active. Their work covers Breast Neoplasms, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation.

Is The University of Kansas Cancer Center - Investigational Drug Services accredited by Crixeo Health?

The University of Kansas Cancer Center - Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Kansas Cancer Center - Investigational Drug Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.